ARTICLES LIST

Clear Search

Select the Article Source National Cancer Institute Office of Dietary Supplements National Institute on Aging Healthfinder.gov National Institute of Child Health and Human Development Centers for Disease Control and Prevention Administration for Children and Families National Institute of Environmental Health Sciences National Library of Medicine National Institute of Allergy and Infectious Diseases National Center for Complementary and Integrative Health National Institute of Neurological Disorders and Stroke NIH Senior Health National Institute of Arthritis and Musculoskeletal and Skin Diseases Health and Human Services National Institute of General Medical Sciences National Institute of Dental and Craniofacial Research National Human Genome Research Institute Food and Drug Administration Center for Tobacco Products Public Health and Medical Emergency Support for a Nation Prepared Office of Disease Prevention and Health Promotion, Healthy People National Institute on Drug Abuse National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases U S Food and Drug Administration National Institute on Deafness and Other Communication Disorders National Heart, Lung, and Blood Institute

Media ID	Source Name	Media Type	Language	Media Name	Media Description	Keywords	Keywords	Link to Article
1339	National Cancer Institute	Html	en	"Light" Cigarettes and Cancer Risk	This fact sheet answers questions about the health effects of smoking	tar yield ratings 0.57737 Tobacco Control Act 0.536069 [PubMed Abstract] 0.48947 lung cancer 0.486686 cigarette engineering 0.5215 cancer prevention study 0.484602 full-flavor cigarettes 0.614325 tobacco 0.630562 tobacco manufacturers 0.618735 Tobacco Control Monograph 0.517669 light cigarette 0.806133 tar 0.70637 color-coded packaging 0.502935 tobacco industry 0.590796 silver packaging 0.501078 tobacco products 0.527514 Family Smoking Prevention 0.526471 President Barack Obama 0.486716 cigarette package design 0.557863 Smoking Cigarettes 0.586945 previously marketed products 0.585107 full-flavor cigarette 0.528959 so-called light cigarette 0.757572 regular cigarettes 0.701052	acute myeloid leukemia 0.482821 safe cigarette 0.580948 National Cancer Institute 0.624018 smoking machine 0.528809 greater tar exposure 0.608329 machine-measured tar yields 0.568171 light cigarettes 0.927757 lower yield 0.510032 Cigarette features 0.526777 frequent puffs 0.539497 USA. Tobacco Control 0.516673 Cigarette tar yields 0.63309 Federal Trade Commission 0.480817 tobacco product 0.533894 Tobacco Control 0.618394 health 0.488561 Low Machine-Measured Yields 0.486658 regular cigarette 0.682678 Certain redesigned cigarettes 0.623296 Chronic Disease Prevention 0.481608 ultralight cigarettes 0.61529 extra cigarettes 0.558295 tobacco industry documents 0.585198 cigarette design 0.541406	CLICK HERE
1346	National Cancer Institute	Html	en	Adult Hodgkin Lymphoma Treatment (PDQ®)–Health Professional Version	Expert-reviewed information summary about the treatment of adult Hodgkin lymphoma.	German Hodgkin 0.354228 German Hodgkin Study 0.30322 Hodgkin Lymphoma Study 0.253534 Hodgkin lymphoma radiotherapy 0.254277 chemotherapy 0.295088 early-stage hodgkin 0.255794 median follow-up 0.203803 early-stage Hodgkin lymphoma 0.241288 disease 0.285786 Abstract 0.418591 Clin Oncol 0.717583 patients 0.627155	Hodgkin lymphoma patients 0.415158 breast cancer 0.396405 Hodgkin disease 0.282385 lymphoma study group 0.228528 Natl Cancer Inst 0.321967 Advanced-stage Hodgkin lymphoma 0.280187 hodgkin lymphoma 0.914677 Hodgkin Study Group 0.304882 radiation therapy 0.591494 Hodgkin lymphoma treatment 0.268627 cancer risk 0.204351 recurrent Hodgkin lymphoma 0.232858	CLICK HERE
1413	National Cancer Institute	Html	en	Delirium (PDQ®)–Patient Version	Expert-reviewed information summary about delirium as a complication of cancer or its treatment. Supportive care and pharmacologic approaches to the management of delirium are discussed.	delirium symptoms 0.709857 nitrogen waste products 0.577723 PDQ cancer information 0.770129 health care team 0.586883 clinical trial search 0.576381 white blood cells 0.577889 clinical trials 0.698332 health care providers 0.640731 cancer information summary 0.69366 health care professionals 0.630449 clinical trial 0.629959 family members 0.626279 breast cancer prevention 0.590247 risk factors 0.581853 PDQ summaries 0.586791 patients 0.70258 cancer patients 0.599627 latest published information 0.583983 NCI’s PDQ 0.59158 NCI PDQ cancer 0.638613 medical conditions 0.583938 mental state 0.591128 treatment 0.629672 medicines 0.581999	cancer prevention 0.590786 Cancer Information Service 0.600573 PDQ Supportive 0.581242 patient 0.833691 treatment clinical trials 0.58693 National Cancer Institute 0.701492 PDQ documents 0.58189 delirium 0.950204 health care 0.718989 Palliative Care Editorial 0.637171 new treatment 0.588734 Cancer Care page 0.597168 PDQ database 0.584618 patient changes 0.579334 Care Editorial Board 0.639637 risk factor 0.616509 PDQ summary 0.609325 cancer clinical trials 0.602276 cancer information summaries 0.605913 health professional versions 0.578381 comprehensive cancer information 0.605614 cancer patient 0.595386 Older patients 0.584199 cancer 0.788674	CLICK HERE
1684	National Cancer Institute	Html	en	Gastrointestinal Stromal Tumors Treatment (PDQ®)–Health Professional Version	Expert-reviewed information summary about the treatment of Gastrointestinal Stromal Tumors	imatinib response 0.41821 higher-dose imatinib mesylate 0.47787 imatinib therapy. 0.433313 Demetri GD 0.381845 TKI imatinib mesylate 0.494206 KIT receptor tyrosine 0.378346 KIT exon 0.370015 gastrointestinal stromal cell 0.41709 KIT-expressing primary GIST 0.416866 small GIST tumors 0.5328 gastrointestinal stromal tumour 0.414558 patients 0.452898 primary GIST 0.421404 complete gross resection 0.401005 adjuvant imatinib 0.525629 gastrointestinal stromal tumor 0.540132 GIST morphology 0.406777 high-dose imatinib 0.421288 stromal tumor resection 0.405207 tyrosine kinase inhibitor 0.379801 GIST patients 0.413735 et al. 0.374864 GIST resection 0.432449 tyrosine kinase 0.423999	metastatic GIST 0.418294 imatinib resistance 0.431916 gastrointestinal stromal tumors 0.903165 recurrent GIST 0.424604 imatinib mesylate 0.752767 imatinib therapy 0.416737 tyrosine kinase inhibitors 0.389426 imatinib ultimately experience 0.466343 GIST range 0.411206 imatinib-resistant GIST 0.405402 GIST 0.738771 Abstract 0.430607 common mesenchymal tumors 0.369545 Clin Oncol 0.46383 imatinib doses 0.430101 imatinib arm 0.426642 Familial GIST 0.424119 indolent GIST 0.42682 gastrointestinal stromal tumours 0.756245 imatinib era 0.421816 inoperable GIST 0.404394 new GIST cases 0.474154 advanced incurable GIST 0.424115 postoperative adjuvant imatinib 0.452036	CLICK HERE
1796	National Cancer Institute	Html	es	Depresión (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca del diagnóstico, evaluación y tratamiento de la depresión en adultos y niños que padecen de cáncer.	PDQ Adaptación 0.900589 pequeño número 0.729693 querido enfermo 0.783448 siguientes aspectos 0.842073 Physician Data Query 0.803023 antidepresivos quizás 0.773298 salud mental 0.794578 suficiente apoyo 0.736237 siguientes razones 0.808967 sustancias químicas ayuda 0.796554 Anfotericina B 0.785281 médico hará preguntas 0.761623	único irdn 0.752807 Red Nacional 0.736951 niños quizás 0.74099 efectos tardíos 0.735838 busque ayuda 0.740646 National Cancer Institute 0.721502 siguientes riesgos 0.72378 siguientes pruebas 0.814768 PDQ Depresión 0.788745 siguientes temas 0.821536 Instituto Nacional 0.830302	CLICK HERE
1988	National Cancer Institute	Html	es	Tratamiento de los tumores de hipófisis (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca del tratamiento de los tumores de hipófisis.	glándula tiroides 0.529036 radiocirugía estereotáctica 0.552565 elabora hormonas 0.687272 cráneo.ampliar craneotomía 0.524586 siguientes aspectos 0.527045 retraso delcrecimiento 0.526689 cuerpo.ampliar anatomía 0.527477 funcionante elabora hormonas 0.57895 Más transpiración 0.522716 Adenomas hipofisarios benignos 0.552964 hormona cortisol 0.560608 cortisol ayuda 0.538031 siguientes tamaños 0.525264 hipófisis causa efectos 0.614286 National Cancer Institute 0.521245 tumores benignos 0.568335 sustancia llamada gadolinio 0.54378	estrías púrpuras 0.526556 siguientes riesgos 0.516532 endocrina múltiple tipo 0.548329 Instituto Nacional 0.536226 hueso esfenoides.ampliar cirugía 0.545911 PDQ Tratamiento 0.543327 alta potencia 0.518465 siguientes problemas 0.529819 siguientes signos 0.538015 suficientes hormonas 0.551735 sistema nervioso central 0.9835 Physician Data Query 0.575155 tratamiento don radiación 0.552351 siguientes enfermedades 0.530576 siguientes operaciones 0.524705 tumores funcionantes 0.567454 cáncer.Las siguientes pruebas 0.55136	CLICK HERE
2107	National Cancer Institute	Html	es	Prevención del cáncer de endometrio (PDQ®)–Versión para pacientes	Sumario de información revisada por expertos sobre factores que pueden influir en el riesgo de presentar cáncer de endometrio y sobre las investigaciones dirigidas a prevenir esta enfermedad.	complementos alimenticios 0.438977 siguientes factores 0.924317 voluntarios sanos 0.439137 Physician Data Query 0.577787 Estados Unidos 0.455812 suficiente ejercicio 0.459491 siguientes enfermedades 0.450904 prevención revisa 0.444255 PDQ Prevención 0.479432	mujer presente cáncer 0.809715 siguientes formas 0.459762 National Cancer Institute 0.445519 efecto protector 0.44325 alta concentración 0.443843 siguientes riesgos 0.434346 edad promedio 0.45542 siguientes sumarios 0.513663 Instituto Nacional 0.483875	CLICK HERE
3457	National Cancer Institute	Html	es	Aromaterapia y aceites esenciales (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca del uso de la aromaterapia y los aceites esenciales para mejorar la calidad de vida de los pacientes de cáncer.	Aromaterapia Holística 0.562365 células madre 0.538543 Centro Nacional 0.523442 cuidado médico 0.513326 New Hampshire Avenue 0.516719 Edad Media 0.513057 Drug Administration 0.51036 materiales básicos 0.513447 NCI Best Case 0.529134 Asociación Nacional 0.510623 International Aromatherapists 0.5134 datos bibliográficos pubmed 0.517834 efectos calmantes 0.525108 índices respiratorios 0.51441 Canadian Federation 0.513125 National Cancer Institute 0.519273 aromaterapia mejora 0.571233 siguientes riesgos 0.511793 frecuencia respiratoria 0.513664 Instituto Nacional 0.589131 acupuntura ayuda 0.509756 antigua china 0.513893	Salud Complementaria 0.537165 Visuals Online 0.511883 complementarias revisa 0.516354 Federación Canadiense 0.511817 Physician Data Query 0.568256 sistema nervioso central 0.524289 verdaderos aceites 0.552975 bacterias mrsa 0.514519 Estados Unidos 0.774616 francés rene gattefosse 0.524782 libre uso 0.513229 National Association 0.51158 PDQ Aromaterapia 0.574967 página manejo 0.510182 ¿El tratamiento 0.520191 International Federation 0.512341 ¿Los beneficios 0.51034 juntos cam 0.50992 Holistic Aromatherapy 0.51402 Series Program 0.51015 medicina complementaria 0.964619	CLICK HERE
16146	National Cancer Institute	Html	es	Virus de la enfermedad de Newcastle (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos sobre el uso del virus de la enfermedad de Newcastle (VEN) como tratamiento para las personas con cáncer.	tumor cell immunogenicity 0.407212 Cancer Res Clin 0.40874 active specific immunotherapy 0.409234 abstract from 0.408151 with newcastle 0.446575 with virus-modified 0.40752 oncolytic virus 0.412098 Reichard KW 0.412175 with virally modified 0.408993 treated postsurgically with 0.409032 Cancer Res 0.456074 Schirrmacher V 0.472403 Csatary LK 0.410713 virus selectively kills 0.408217 Natl Cancer Inst 0.453624 human tumor 0.419154 immunotherapy with 0.411294 Attenuated veterinary virus 0.408258 Ahlert T 0.417009 patients with 0.422834 autologous tumor cells 0.443634 immunotherapy with virally 0.409777 immunization with 0.407432 Lorence RM 0.416992 modified autologous tumor 0.409356	newcastle disease virus 0.990705 virus infeccioso destrucción 0.419778 Lítica Virus 0.418733 virus as 0.414895 tumor cell modification 0.407198 tumor cells 0.594311 virus therapy 0.428512 specific immunotherapy 0.411581 postsurgically with newcastle 0.414603 Cassel WA 0.412481 tumor vaccines 0.414853 Clin Oncol 0.407495 patient with 0.407334 virus mutant with 0.411813 after local newcastle 0.411338 postoperative immunotherapy with 0.409993 malignant melanoma patients 0.409365 with tumor cells 0.411774 renal cell carcinoma 0.40842 malignant melanoma 0.414222 tumor necrosis 0.410434 in vitro 0.430542 virus is reviving 0.408425 active specific 0.412889	CLICK HERE
17172	National Cancer Institute	Html	es	Hongos medicinales (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos sobre el uso de los hongos medicinales como tratamiento para las personas con cáncer.	tumores colorrectales benignos 0.523017 Centro Nacional 0.437112 New Hampshire Avenue 0.425865 Coriolus versicolor 0.603005 Drug Administration 0.41603 NCI Best Case 0.44366 hongo tejado 0.42735 hongos trametes 0.464694 tipo ganoderma 0.427842 datos bibliográficos pubmed 0.427701 siguientes preguntas 0.418216 células t 0.427868 hongos cola 0.470178 siguientes riesgos 0.422485 Instituto Nacional 0.543935 Ganoderma lucidum 0.60047 Salud Complementaria 0.454998 Visuals Online 0.419017	sumario hongos 0.465605 polisacárido -K 0.427899 complementarias revisa 0.427138 Physician Data Query 0.509146 Estados Unidos 0.759861 estadio iii 0.424138 libre uso 0.423898 Lentinus edodes 0.430494 Asia Oriental 0.421328 página manejo 0.417832 ¿El tratamiento 0.429283 inmunitarias llamadas linfocitos 0.447603 ¿Los beneficios 0.416234 juntos cam 0.415492 Series Program 0.416063 medicina complementaria 0.932021 Trametes versicolor 0.613189 tipo cola 0.441661	CLICK HERE